Latest Innovation News

Stakk Limited has secured a pivotal three-year contract with T-Mobile USA to embed its finance technology within the T-Life Super App, marking a significant expansion into the U.S. telecom sector.

Orthocell has appointed its first Canadian distributor for Remplir, its innovative nerve repair device, ahead of an official launch at a major surgical conference in Vancouver. The move marks a significant step in expanding the product’s international footprint.

InFocus Group Holdings has launched a dedicated iGaming business unit, aiming to capitalize on the booming $95 billion online gaming industry with key contracts and digital asset integration.

Dimerix Limited’s lead drug candidate DMX-200 has been granted Orphan Drug Designation in Japan for treating Focal Segmental Glomerulosclerosis (FSGS), enhancing its regulatory and commercial prospects in a key market.

Metals Australia Ltd reveals a 3.3-fold increase in its Lac Carheil graphite resource alongside promising assay results for precious and base metals, setting the stage for value-added by-product recovery.

Aquirian Limited reports a 16.7% revenue increase alongside key operational advances at its Wubin facility and new leadership appointments, signaling strong momentum in mining services and technology.

Imagion Biosystems has completed the second tranche of its $3.5 million placement, raising $2.85 million to advance its proprietary MagSense® imaging technology targeting breast, prostate, and ovarian cancers.

CurveBeam AI Limited has secured A$6.5 million in new capital to fuel global growth of its HiRise™ weight-bearing CT scanner, deepen its partnership with orthopaedic giant Stryker, and advance a potential strategic deal in China.

CurveBeam AI has secured A$6.5 million through an institutional placement and completed a €10 million vendor financing facility to accelerate sales of its HiRise™ CT scanner. The company is also progressing a strategic partnership in China and advancing surgical robot validation.

Mayne Pharma’s innovative oral contraceptive NEXTSTELLIS® has secured reimbursement under Australia’s Pharmaceutical Benefits Scheme, making it significantly more affordable and broadening contraceptive options nationwide.

RocketDNA Ltd has landed a $450,000 contract with BHP Mitsubishi Alliance to operate three SurveyBot drone units over nine months, reinforcing its foothold in the mining sector.

Australian Unity Limited has appointed Kelly Bayer Rosmarin as its next Group Managing Director and CEO, succeeding Rohan Mead after his 21-year tenure. Bayer Rosmarin’s leadership is expected to drive the company’s strategic transformation and growth in wellbeing services.